Trademark: 76687381
Word
XEDITON
Status
Dead
Status Code
602
Status Date
Saturday, May 19, 2012
Serial Number
76687381
Mark Type
4000
Filing Date
Wednesday, March 5, 2008
Abandoned Date
Thursday, April 19, 2012

Trademark Owner History

Classifications
5 Vitamins, minerals, dietary supplements; pharmaceuticals, namely, pharmaceutical preparations and substances for the prevention and treatment of diseases and disorders of the digestive system, endocrine system, integumentary system, lymphatic system, muscular system, nervous system, immune system, cardiovascular system, metabolic system, reproductive system, respiratory system, skeletal system, urinary system, and eyes; pharmaceuticals, namely, pharmaceutical preparations and substances for use in gastroenterology, oncology, ophthalmology, cardiology, dermatology, haematology, chemotherapy, psychiatry, urology, and neurology; pharmaceuticals, namely, pharmaceutical preparations and substances for the prevention and treatment of blood disorders, cancer, cardiovascular diseases, carpal tunnel syndrome, dental and oral diseases, headaches, pain, varicose veins, erectile dysfunction, gout, heart rhythm disorders, infectious diseases, gastro-intestinal diseases, diabetes, skin disorders, wounds, eye diseases and disorders, bacteria based diseases, inflamation, sepsis, alopecia, obesity, cognitive disorders, bone diseases, and viruses; pharmaceuticals, namely, pharmaceutical preparations for the treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, and inflammatory pelvic diseases; pharmaceuticals, namely, pharmaceutical preparations for the treatment of immunologic diseases, namely, auto-immune diseases and immunologic deficiency syndrome; pharmaceuticals, namely, pharmaceutical preparations for the treatment of infectious diseases, namely, respiratory infections, and eye infections; pharmaceuticals, namely, pharmaceutical preparations for the treatment of inflammatory diseases, namely, inflammatory bowel diseases, and inflammatory connective tissue diseases; pharmaceuticals, namely, pharmaceutical preparations for the treatment of neurological diseases and disorders, namely, Alzheimer's, Huntington's Disease, cerebral palsy, brain injuries, spinal cord injuries, and seizures; pharmaceuticals, namely, pharmaceutical preparations for the treatment of psychiatric diseases and disorders, namely, mood disorders, anxiety disorders, cognitive diseases, and schizophrenia; pharmaceuticals, namely, pharmaceutical preparations for the treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular mobility disorders, and spinal cord diseases; pharmaceuticals, namely, pharmaceutical preparations for the treatment of the central nervous system, namely, encephalitis, epilepsy, Alzheimer's, cerebral palsy, and Parkinson's disease; pharmaceuticals, namely, pharmaceutical preparations for the treatment of the musculoskeletal system, namely, connective tissue disorders, bone diseases, spinal diseases, back pain, fractures, sprains, and cartilage injuries; pharmaceuticals, namely, pharmaceutical preparations for the treatment of viral diseases, namely, herpes, hepatitis, and Acquired Immune Deficiency Syndrome (AIDS); pharmaceuticals, namely, pharmaceutical preparations for the treatment of skin diseases and disorders, namely, dermatitis, skin pigmentation diseases, and sexually transmitted diseases; nutraceuticals, namely, vitamin, mineral and herbal food supplements; pharmaceuticals, namely, analgesics, muscle relaxants, antibacterial, anti-diabetics, antimicrobial preservatives, astringents, antitussive-cold preparations, anti-allergic preparations, anticoagulants antidepressants, appetite suppressants, vaccines, anti fungal preparations, antibiotics, anti-infective preparations, antiviral preparations, psychotropics, lipid lowering agents, anthelmintics, and skin lotions; nutraceuticals, namely, nutraceutical preparations and substances for the prevention and treatment of diseases and disorders of the digestive system, endocrine system, integumentary system, lymphatic system, muscular system, nervous system, immune system, cardiovascular system, metabolic system, reproductive system, respiratory system, skeletal system, urinary system, and eyes; nutraceuticals, namely, nutraceutical preparations and substances for use in gastroenterology, oncology, ophthalmology, cardiology, dermatology, haematology, chemotherapy, psychiatry, urology, and neurology; nutraceuticals, namely, nutraceutical preparations and substances for the prevention and treatment of blood disorders, cancer, cardiovascular diseases, carpal tunnel syndrome, dental and oral diseases, headaches, pain, varicose veins, erectile dysfunction, gout, heart rhythm disorders, infectious diseases, gastro-intestinal diseases, diabetes, skin disorders, wounds, eye diseases and disorders, bacteria based diseases, inflamation, sepsis, alopecia, obesity, cognitive disorders, bone diseases, and viruses; nutraceuticals, namely, nutraceutical preparations for the treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, and inflammatory pelvic diseases; nutraceuticals, namely, nutraceutical preparations for the treatment of immunologic diseases, namely, auto-immune diseases and immunologic deficiency syndrome; nutraceuticals, namely, nutraceutical preparations for the treatment of infectious diseases, namely, respiratory infections, and eye infections; nutraceuticals, namely, nutraceutical preparations for the treatment of inflammatory diseases, namely, inflammatory bowel diseases, and inflammatory connective tissue diseases; nutraceuticals, namely, nutraceutical preparations for the treatment of neurological diseases and disorders, namely, Alzheimer's, Huntington's Disease, cerebral palsy, brain injuries, spinal cord injuries, and seizures; nutraceuticals, namely, nutraceutical preparations for the treatment of psychiatric diseases and disorders, namely, mood disorders, anxiety disorders, cognitive diseases, and schizophrenia; nutraceuticals, namely, nutraceutical preparations for the treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular mobility disorders, and spinal cord diseases; nutraceuticals, namely, nutraceutical preparations for the treatment of the central nervous system, namely, encephalitis, epilepsy, Alzheimer's, cerebral palsy, and Parkinson's disease; nutraceuticals, namely, nutraceutical preparations for the treatment of the musculoskeletal system, namely, connective tissue disorders, bone diseases, spinal diseases, back pain, fractures, sprains, and cartilage injuries; nutraceuticals, namely, nutraceutical preparations for the treatment of viral diseases, namely, herpes, hepatitis, and Acquired Immune Deficiency Syndrome (AIDS); nutraceuticals, namely, nutraceutical preparations for the treatment of skin diseases and disorders, namely, dermatitis, skin pigmentation diseases, and sexually transmitted diseases; nutraceuticals, namely, analgesics, muscle relaxants, antibacterial, anti-diabetics, antimicrobial preservatives, astringents, antitussive-cold preparations, anti-allergic preparations, anticoagulants, antidepressants, appetite suppressants, vaccines, anti fungal preparations, antibiotics, anti-infective preparations, antiviral preparations, psychotropics, lipid lowering agents, anthelmintics, and skin lotions; chemicals for medicinal purposes, namely, calcium, hydrogen, iodine, iron, sodium, super, zinc
35 Providing consumer product information on pharmaceuticals, nutraceuticals, vitamins, minerals, dietary supplements, chemicals for medicinal purposes and medical devices and appliances

Trademark Events
May 21, 2012
Abandonment Notice Mailed - Failure To Respond
May 19, 2012
Abandonment - Failure To Respond Or Late Response
Oct 19, 2011
Inquiry As To Suspension Mailed
Oct 18, 2011
Suspension Inquiry Written
Oct 11, 2011
Lie Checked Susp - To Atty For Action
Jul 20, 2011
Applicant/Correspondence Changes (Non-Responsive) Entered
Jul 20, 2011
Teas Change Of Owner Address Received
Apr 11, 2011
Letter Of Suspension Mailed
Apr 8, 2011
Suspension Letter Written
Apr 4, 2011
Amendment From Applicant Entered
Apr 4, 2011
Correspondence Received In Law Office
Mar 18, 2011
Assigned To Lie
Mar 17, 2011
Fax Received
Sep 20, 2010
Inquiry As To Suspension Mailed
Sep 17, 2010
Suspension Inquiry Written
Mar 15, 2010
Letter Of Suspension Mailed
Mar 12, 2010
Suspension Letter Written
Mar 10, 2010
Amendment From Applicant Entered
Mar 10, 2010
Correspondence Received In Law Office
Mar 8, 2010
Fax Received
Sep 8, 2009
Inquiry As To Suspension Mailed
Sep 5, 2009
Suspension Inquiry Written
Mar 5, 2009
Letter Of Suspension Mailed
Mar 4, 2009
Suspension Letter Written
Jan 7, 2009
Amendment From Applicant Entered
Jan 7, 2009
Correspondence Received In Law Office
Jan 7, 2009
Assigned To Lie
Dec 23, 2008
Paper Received
Jun 23, 2008
Non-Final Action Mailed
Jun 23, 2008
Non-Final Action Written
Jun 15, 2008
Assigned To Examiner
Mar 15, 2008
Application Filing Receipt Mailed
Mar 11, 2008
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24